Matteo Trucco

Associate Professor

Cleveland Clinic

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Matteo Trucco is an Associate Professor at Cleveland Clinic in the United States. His research primarily focuses on pediatric oncology, particularly in the management of sarcomas including Ewing sarcoma and osteosarcoma. He has contributed to several clinical trials and consensus recommendations that address systemic therapies and innovative treatment approaches in this field.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Matthew Dietz

Assistant Professor

University of Utah

UNITED STATES

View details

Ajay Gupta

Assistant Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Masanori Hayashi

Assistant Professor

University of Colorado Boulder

UNITED STATES

View details

Leo Mascarenhas

UNITED STATES

View details

Scott Borinstein

Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Amy Armstrong

Assistant Professor

Washington University Physicians

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Matteo Trucco

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation

Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board.

Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation.

Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of "Fusion-Positive" Cases.

Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.

Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials

Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor Board

A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation

DNA Methylation Profiling Distinguishes Adamantinoma-Like Ewing Sarcoma From Conventional Ewing Sarcoma

Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma

Collaborators (6)

Matthew Dietz

Ajay Gupta

Masanori Hayashi

Leo Mascarenhas

Scott Borinstein

Amy Armstrong

Make your next move.